drug protocol number

EFC17359

drug sponsor

Sanofi / Arab Med

drug study

Rilzabrutinib

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase